A Monoclonal Antibody against Wnt-1 Induces Apoptosis in Human Cancer Cells

Neoplasia

Volumn 6, Issue 1, 2004, Pages 7-14

  He, Biao ^a   You, Liang ^a   Uematsu, Kazutsugu ^a   Xu, Zhidong ^a   Lee, Amie Y ^a   Matsangou, Maria ^a   McCormick, Frank ^a   Jablons, David M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Cancer Center   (United States)

Author keywords

Apoptosis; Cancer; Human; Monoclonal antibody; Wnt 1

Indexed keywords

MONOCLONAL ANTIBODY; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; WNT 1 MONOCLONAL ANTIBODY; WNT1 PROTEIN;

ADOLESCENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CANCER THERAPY; CARCINOGENESIS; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MESOTHELIOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE; SARCOMA; SIGNAL TRANSDUCTION;

EID: 1642341682     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1476-5586(04)80048-4     Document Type: Article

References (26)

1. Uthoff SM, Eichenberger MR, McAuliffe TL, Hamilton CJ, and Galandiuk S (2001). Wingless-type frizzled protein receptor signaling and its putative role in human colon cancer. Mol Carcinog 31, 56-62.
2. Polakis P (2000). Wnt signaling and cancer. Genes Dev 14, 1837-1851.
3. Sadot E, Geiger B, Oren M, and Ben-Ze'ev A (2001). Down-regulation of beta-catenin by activated p53. Mol Cell Biol 21, 6768-6781.
4. Matsuzawa SI and Reed JC (2001). Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. Mol Cell 7, 915-926.
5. Li L, Yuan H, Weaver CD, Mao J, Farr GH, III, Sussman DJ, Jonkers J, Kimelman D, and Wu D (1999). Axin and Frat1 interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1. EMBO J 18, 4233-4240.
6. Yamamoto H, Kishida S, Kishida M, Ikeda S, Takada S, and Kikuchi A (1999). Phosphorylation of axin, a Wnt signal negative regulator, by glycogen synthase kinase-3beta regulates its stability. J Biol Chem 274, 10681-10684.
7. Hart M, Concordet JP, Lassot I, Albert I, del los Santos R, Durand H, Perret C, Rubinfeld B, Margottin F, Benarous R, and Polakis P (1999). The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Curr Biol 9, 207-210.
8. Peifer M and Polakis P (2000). Wnt signaling in oncogenesis and embryogenesis-a look outside the nucleus. Science 287, 1606-1609.
9. Bienz M and Clevers H (2000). Linking colorectal cancer to Wnt signaling. Cell 103, 311-320.
10. Brown AM (2001). Wnt signaling in breast cancer: have we come full circle? Breast Cancer Res 3, 351-355.
11. You Z, Saims D, Chen S, Zhang Z, Guttridge DC, Guan KL, MacDougald OA, Brown AM, Evan G, Kitajewski J, and Wang CY (2002). Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis. J Cell Biol 157, 429-440.
12. Katoh M (2003). Expression and regulation of WNT1 in human cancer: up-regulation of WNT1 by beta-estradiol in MCF-7 cells. Int J Oncol 22, 209-212.
13. Wong SC, Lo SF, Lee KC, Yam JW, Chan JK, and Hsiao WL (2002). Expression of frizzled-related protein and Wnt-signalling molecules in invasive human breast tumours. J Pathol 196, 145-153.
14. Elbashir SM, Harborth J, Weber K, and Tuschl T (2002). Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26, 199-213.
15. Wang CY, Guttridge DC, Mayo MW, and Baldwin AS Jr. (1999). NF-kB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol Cell Biol 19, 5923-5929.
16. Uematsu K, Kanazawa S, You L, He B, Xu Z, Peterlin M, McCormick F, and Jablons DM (2003). Wnt pathway activation in mesothelioma: evidence of Dishevelled overexpression and transcriptional activity of beta-catenin. Cancer Res 63, 4547-4551.
17. Sonoda Y, Ozawa T, Hirose Y, Aldape KD, McMahon M, Berger MS, and Pieper RO (2001). Formation of intracranial tumor by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma. Cancer Res 61, 4956-4960.
18. Uematsu K, He B, You L, Xu Z, McCormick F, and Jablons DM (2003). Activation of the Wnt pathway in non-small-cell lung cancer: evidence of Dishevelled overexpression. Oncogene 22, 7218-7221.
19. Orsulic S, Huber O, Aberle H, Arnold S, and Kemler R (1999). E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation. J Cell Sci 112, 1237-1245.
20. Miller JR (2002). The Wnts. Genome Biol 3, 1-15 REVIEWS 3001.
21. van Gijn ME, Daemen MJ, Smits JF, and Blankesteijn WM (2002). The Wnt-frizzled cascade in cardiovascular disease. Cardiovasc Res 55, 16-24.
22. Rhee CS, Sen M, Lu D, Wu C, Leoni L, Rubin J, Corr M, and Carson DA (2002). Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas. Oncogene 21, 6598-6605.
23. Chen S, Guttridge DC, You Z, Zhang Z, Fribley A, Mayo MW, Kitajewski J, and Wang CY (2001). Wnt-1 signaling inhibits apoptosis by activating β-catenin/T cell factor-mediated transcription. J Cell Biol 152, 87-96.
24. Longo KA, Kennell JA, Ochocinska MJ, Ross SE, Wright WS, and MacDougald OA (2002). Wnt signaling protects 3T3-L1 preadipocytes from apoptosis through induction of insulin-like growth factors. J Biol Chem 277, 38239-38244.
25. Song L, De Sarno P, and Jope RS (2002). Central role of glycogen synthase kinase-3beta in endoplasmic reticulum stress-induced caspase-3 activation. J Biol Chem 277, 44701-44708.
26. Xia C, Xu Z, Yuan X, Uematsu K, You L, Li K, Li L, McCormick F, and Jablons DM (2002). Induction of apoptosis in mesothelioma cells by antisurvivin oligonucleotides. Mol Cancer Ther 1, 687-694.